Yonghe Zhongxing Public Seniors Center
New Taipei City, 234, Taiwan
NCT Number: NCT04507633
This study aimed to conduct a randomized controlled trial to examine the effectiveness of ROMA therapy( Reminiscence, Reality Orientation, Music, and Art) on improving cognitive function, behavioral and psychological symptoms in population with dementia. The hypotheis of this study is that these patients with dementia receiving ROMA therapy featuring reminiscence, reality orientation, music, and art would improve their cognition, depressive symptoms, and behavioral symptoms.
Looking for future studies?
Notify Me65 year and older
All sexes
Interventional
Not applicable
New Taipei City, 234, Taiwan
This study aimed to conduct a randomized controlled trial to examine the effectiveness of ROMA therapy( Reminiscence, Reality Orientation, Music, and Art) on improving cognitive function, behavioral and psychological symptoms in demented population. A total of 60 patients with mild to moderate dementia will be recruited and randomly assigned to two groups: experimental group and control group. The experimental group will undergo ROMA therapy with a 60 minute per week for eight weeks. The control group will receive three times ROMA therapy after completing outcome measurements. Two groups will receive questionnaire interview at pre-test, post-test, and at 4 weeks after intervention. The measurements comprises: Short Portable Mental Status Questionnaire(SPMSQ), Cornell Scale for Depression in Dementia(CSDD),and Neuropsychiatric Inventory-Questionnaire(NPI-Q). By identifying the effectiveness of ROMA therapy, suitable intervention can be suggested for those demented population to improve cognitive function, behavioral and psychological symptoms.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
An intervention comprising reminiscence of annual festivals, orientation, and familiar music listening and singing, and animation interaction to improve cognitive functions, depressive symptoms and behaviors problems.
Time frame: cognitive functions at baseline
Short Portable Mental Status Questionnaire(SPMSQ)
Time frame: cognitive functions after the completion of intervention
Short Portable Mental Status Questionnaire(SPMSQ)
Time frame: cognitive functions at 4 weeks after the completion of intervention
Short Portable Mental Status Questionnaire(SPMSQ)
Time frame: depressive symptoms at baseline
Cornell Scale for Depression in Dementia(CSDD)
Time frame: depressive symptoms after the completion of intervention
Cornell Scale for Depression in Dementia(CSDD)
Time frame: depressive symptoms at 4 weeks after the completion of intervention
Cornell Scale for Depression in Dementia(CSDD)
Time frame: behavioral problems at baseline
Neuropsychiatric Inventory-Questionnaire(NPI-Q)
Time frame: behavioral problems after the completion of intervention
Neuropsychiatric Inventory-Questionnaire(NPI-Q)
Time frame: behavioral problems at 4 weeks after the completion of intervention
Neuropsychiatric Inventory-Questionnaire(NPI-Q)
Taipei Medical University
Other
The Effect of ROMA Therapy on Improving Cognitive Functions, Depressive Symptoms and Behavioral Problems in the Population With Dementia
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06347172
Alzheimer Disease, Brain Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT07306065
Alzheimer Disease, Alzheimers Disease
Orlando, Florida, United States
View Trial DetailsNCT04992195
Alzheimer Disease, Arterial Thromboembolism
Hong Kong
View Trial DetailsNCT05529706
Alzheimer Disease, Brain Diseases
San Francisco, California, United States
View Trial Details